Zhejiang Chemsyn Pharm CoBJSE:920656 36 Net Margin % is 30.61% as of Mar. 2026, which is 1% below its 10-year median of 31.01. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks better than 94.44% on this metric.
The historical rank and industry rank for Zhejiang Chemsyn Pharm Co's Net Margin % or its related term are showing as below:
BJSE:920656'
s Net Margin % Range Over the Past 10 Years
Min: 2.74 Med: 31.01 Max: 43.34
Current: 31.23
BJSE:920656's Net Margin % is ranked better than 94.44% of 18
companies
in the Healthcare Plans industry
Industry Median: 0.95
vs BJSE:920656: 31.23
Zhejiang Chemsyn Pharm Co (BJSE:920656) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Zhejiang Chemsyn Pharm Co Net Margin % Related Terms
Zhejiang Chemsyn Pharm Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920656 vs UNH, CVS, ELV: Net Margin % Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co Net Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Net Margin % of 30.61% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is near median its historical median of 31.01. Over the past decade, Zhejiang Chemsyn Pharm Co's Net Margin % has ranged from 2.74 to 43.34. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #1 out of 18 companies in the Healthcare Plans industry, placing it in the top 5.6%.
Is Zhejiang Chemsyn Pharm Co's Net Margin % too high?
Zhejiang Chemsyn Pharm Co's current Net Margin % of 30.61% is near median its 10-year median of 31.01. Over the past 10 years, this metric has ranged from a low of 2.74 to a high of 43.34. The Healthcare Plans industry median Net Margin % is 0.95. Zhejiang Chemsyn Pharm Co's value of 30.61% is 3122.1% above this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #1 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Net Margin % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #1 out of 18 companies for Net Margin %. This places Zhejiang Chemsyn Pharm Co in the top 6% of its industry — outperforming the majority of peers. The industry median Net Margin % is 0.95. Zhejiang Chemsyn Pharm Co's value of 30.61% is 3122.1% above this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own Net Margin % has ranged from 2.74 to 43.34 over the past decade. While the company's 10-year median is 31.01 vs. the industry median of 0.95, Zhejiang Chemsyn Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Plans company?
The median Net Margin % among Healthcare Plans companies is 0.95, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current Net Margin % of 30.61% is 3122.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median Net Margin % is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current Net Margin % is 30.61%, which is near median its own 10-year median of 31.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current Net Margin % of 30.61%. The current Net Margin % is 30.61%, which is near median its 10-year median of 31.01 and 3122.1% above the Healthcare Plans industry median of 0.95. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Net Margin % is 30.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
